Keywords
Documents disponibles dans cette catégorie (837)
Article
Bird TD | 25/04/2024Initial Posting: September 28, 1998; Last Revision: April 25, 2024. The purpose of this overview is to increase the awareness of clinicians regarding Charcot-Marie-Tooth (CMT) hereditary neuropathy, its causes, and its management. The followi[...]Article
Abrams CK | 25/04/2024Initial Posting: June 18, 1998; Last Revision: April 25, 2024. Clinical characteristics : GJB1 disorders are typically characterized by peripheral motor and sensory neuropathy with or without fixed CNS abnormalities and/or acute, self-limite[...]Article
Bird TD | 21/03/2024Initial Posting: September 17, 1999; Last Revision: March 21, 2024. Clinical characteristics. Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, an[...]Article
Thada PK ; Bhandari J ; Umapathi KK | 30/01/2024Last Update: January 30, 2024 [Previous update: May 29, 2023]Article
Wirth T ; Bonnet C ; Delvallée C ; Pellerin D ; Bogdan T ; Clément G ; Schalk A ; Chanson JB ; Fleury MC ; Piton A ; Calmels N ; Namer IJ ; Kremer S ; Brais B ; Tranchant C ; Renaud M ; Anheim M | 23/01/2024Article
Pugliese A ; Della Marina A ; de Paula Estephan E ; Zanoteli E ; Roos A ; Schara-Schmidt U ; Hentschel A ; Azuma Y ; Topf A ; Thompson R ; Polavarapu K ; Lochmuller H | 04/11/2023Article
Initial Posting: August 31, 2007; Last Revision: November 2, 2023. Clinical characteristics. Pompe disease is classified by age of onset, organ involvement, severity, and rate of progression. Infantile-onset Pompe disease (IOPD; indiv[...]Article
Cluse F ; Hermier M ; Demarquay G ; Rogemond V ; Mallaret M ; Svahn J ; Pégat A ; Honnorat J ; Bernard E | 22/08/2023Article
Last Update: August 22, 2023. [Previous version: 2020]Article
Last Update: August 14, 2023. [Published : May 9, 2022]Article
Article
Last Update: August 12, 2023. [Revious version February 15, 2022]Article
Leslie ND ; Saenz-Ayala S | 13/07/2023In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 Initial Posting: May 28, 2009; Last Revision: July 13, 2023 (Previous Update: June 16, 2022) CLINICAL CHARACT[...]Article
Article
Uneoka S ; Kobayashi T ; Numata-Uematsu Y ; Oikawa Y ; Katata Y ; Okubo Y ; Abe Y ; Kikuchi A ; Takayama J ; Tamiya G ; Kure S ; Saito K ; Uematsu M | 12/06/2023Article
Article
Last Update: May 29, 2023 ( Published : June 24, 2020, Previous update : May 9, 2022)Article
Last Update: May 29, 2023 [Previous update: May 8, 2022]Article
Last Update: May 25, 2023. [Previous version: August 10, 2020]Article
Sangadala S ; Shore EM ; Xu M ; Bergwitz C ; Lozano-Calderon SA ; Lin AE ; Boden SD ; Kaplan FS | 23/05/2023Article
In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Initial Posting: March 30, 2023. CLINICAL CHARACTERISTICS: CHKB-related muscular dystrophy (CHKB-MD), r[...]Article
Di Feo MF ; Lillback V ; Jokela M ; McEntagart M ; Homfray T ; Giorgio E ; Casalis Cavalchini GC ; Brusco A ; Iascone M ; Spaccini L ; D'Oria P ; Savarese M ; Udd B | England | 28/03/2023Article
Article
Article
Article
La Spada A | 15/12/2022Initial Posting: February 26, 1999; Last Update: December 15, 2022. Clinical characteristics. Spinal and bulbar muscular atrophy (SBMA) is a gradually progressive neuromuscular disorder in which degeneration of lower motor neurons results in[...]Article
Granger A ; Beecher G ; Liewluck T ; Nicolau S ; Flanigan KM ; Laughlin RS ; Milone M | England | 15/12/2022Article
Ogasawara M ; Eura N ; Iida A ; Kumutpongpanich T ; Minami N ; Nonaka I ; Hayashi S ; Noguchi S ; Nishino I | England | 07/12/2022Article
Angelini C | 01/12/2022Initial Posting: May 10, 2005; Last Update: December 1, 2022. Clinical characteristics. Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. Clinical findings of calpainopathy include the tend[...]Guide
Collectif | 11/2022Ce protocole national de diagnostic et de soins (PNDS) explicite aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale et le parcours de soins des patients atteints de myopathies liées au collagène de type VI (CO[...]Article
Last Update: October 10, 2022 [Previous update: July 12, 2021; February 15, 2021]Guide
Collectif | 10/2022Ce protocole national de diagnostic et de soins (PNDS) explicite aux professionnels concernés la prise en charge diagnostique et thérapeutique optimale et le parcours de soins d’un malade atteint de laminopathie avec atteinte cardiaque. Il a été[...]Article
Article
Jain A ; Al Khalili Y | 21/07/2022Last Update: July 21, 2022 (Previous versions : July 10, 2021 - December 15, 2020)Article
Article
Last Update: July 18, 2022 (previous version : November 20, 2020)Article
Article
Article
Al Shehri A ; Al-Asmi A ; Al Salti AM ; Almadani A ; Hassan A ; Bamaga AK ; Cupler EJ ; Al-Hashel J ; Alabdali MM ; Alanazy MH ; Noori S | Netherlands | 23/06/2022Article
Last Update: July 8, 2021. (previous version July 8, 2020)Article
Last Update: May 8, 2022. (previous version July 6, 2021)Article
Last Update: May 8, 2022 (previous version May 9, 2021)Article
Last Update: May 8, 2022 (Previous update : October 10, 2021)Article
Last Update: May 15, 2022 . (previous version July 4, 2021)Article
Pfeffer G ; Chinnery PF | 14/04/2022Initial Posting: February 27, 2014; Last Update: April 14, 2022. Clinical characteristics. Hereditary myopathy with early respiratory failure (HMERF) is a slowly progressive myopathy that typically begins in the third to fifth decades of l[...]Article
Pichette E ; O'Ferrall E ; Karamchandani J ; Savarese M ; Udd B ; Massie R | Netherlands | 29/01/2022Article
Article
Pelosi L ; Pelosi L ; Ghosh A ; Leadbetter R ; Lance S ; Rodrigues M ; Roxburgh R | United States | 28/01/2022Article
Initial Posting: September 5, 2000; Last Revision: January 20, 2022. Clinical characteristics. The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker[...]Article
Last Update: January 9, 2022 (previous version August 14, 2021; August 15, 2020)Article
Schreuder AB ; Rossi A ; Grünert SC ; Derks TGJ | 06/01/2022Initial Posting: March 9, 2010; Last Update: January 6, 2022. Clinical characteristics. Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most c[...]Article
Article
Article
Abicht A ; Müller J ; Lochmuller H | 23/12/2021Initial Posting: May 9, 2003; Last Update: December 23, 2021. The purpose of this overview is to increase the awareness of clinicians regarding congenital myasthenic syndromes (CMS) and their genetic causes and management. The following ar[...]Article
Mahler M ; Malyavantham K ; Seaman A ; Bentow C ; Anunciacion-Llunell A ; Sanz-Martinez MT ; Viñas-Gimenez L ; Selva-O Callaghan A | 30/11/2021Article
Nous présentons le cas d’un patient de 45 ans, premier d’une fratrie de deux enfants issus de parents consanguins d’origine française.Article
Opal P | 14/10/2021Initial Posting: January 9, 2003; Last Update: October 14, 2021. Clinical characteristics. GAN-related neurodegeneration comprises a phenotypic continuum ranging from severe (sometimes called classic giant axonal neuropathy) to milder pure[...]Article
Article
Article
Article
Article
Article
Article
Jayarangaiah A ; Theetha Kariyanna P | 15/07/2021Last Update: July 15, 2021. (previous version July 15, 2020)Article
Last Update: July 14, 2021. (previous version November 19, 2020)Article
Article
Last Update: July 7, 2021. [Previous update: February 13, 2021]Article
Article
Weber F | 01/07/2021Initial Posting: July 18, 2003; Last Update: July 1, 2021. Clinical characteristics. Hyperkalemic periodic paralysis (hyperPP) is characterized by attacks of flaccid limb weakness (which may also include weakness of the muscles of the eyes[...]Article
Article
Article
Hauw F ; Fargeot G ; Adams D ; Attarian S ; Cauquil C ; Chanson JB ; Creange A ; Gendre T ; Deiva K ; Delmont E ; Francou B ; Genestet S ; Kuntzer T ; Latour P ; Le Masson G ; Magy L ; Nardin C ; Ochsner F ; Sole G ; Stojkovic T ; Maisonobe T ; Tard C ; Van den Berghe P ; Echaniz-Laguna A | England | 01/06/2021Article
Aoki M ; Takahashi T | 27/05/2021Initial Posting: February 5, 2004; Last Update: May 27, 2021. Clinical characteristics. Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular [...]Article
Last Update: May 7, 2021 (previous version June 3, 2020)Article
Takizawa H ; Mori Yoshimura M ; Minami N ; Murakami N ; Yatabe K ; Taira K ; Hashimoto Y ; Aoki Y ; Nishino I ; Takahashi Y | England | 27/04/2021Article
Initial Posting: June 11, 2015; Last Update: April 8, 2021 Clinical description. Riboflavin transporter deficiency (RTD), comprising RTD2 and RTD3 (caused by biallelic pathogenic variants in SLC52A2 and SLC52A3, respectively) is a rare neu[...]Article
Foley AR ; Mohassel P ; Donkervoort S ; Bolduc V ; Bonnemann CG | 11/03/2021Initial Posting: June 25, 2004; Last Update: March 11, 2021. Clinical characteristics. Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, U[...]Article
Azzedine H ; Salih MA | 11/03/2021Initial Posting: March 31, 2008; Last Update: March 11, 2021. Clinical characteristics. SH3TC2-related hereditary motor and sensory neuropathy (SH3TC2-HMSN) is a demyelinating neuropathy characterized by severe spine deformities (scoliosis[...]Article
Initial Posting: August 3, 2005; Last Update: February 25, 2021. Clinical characteristics. Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, faci[...]Article
Article
Velez-Bartolomei F ; Lee C ; Enns G | 07/01/2021Initial Posting: June 3, 2003; Last Update: January 7, 2021. Clinical characteristics. MERRF (myoclonic epilepsy with ragged red fibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized[...]Article
Prior TW ; Leach ME ; Finanger E | 3/12/2020Initial Posting: February 24, 2000; Last Revision: December 3, 2020. Clinical characteristics. Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of t[...]Article
Article
Trollet C ; Boulinguiez A ; Roth F ; Stojkovic T ; Butler Browne G ; Evangelista T ; Lacau St Guily J ; Richard P | 22/10/2020Initial Posting: March 8, 2001; Last Update: October 22, 2020. Clinical characteristics. Oculopharyngeal muscular dystrophy (OPMD) is characterized by ptosis and dysphagia due to selective involvement of the muscles of the eyelids and phar[...]Article
McCray BA ; Schindler A ; Hoover-Fong JE ; Sumner CJ | 17/09/2020Initial Posting: May 15, 2014; Last Update: September 17, 2020. Clinical characteristics. The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are n[...]Article
Initial Posting: April 2, 2009; Last Update: September 17, 2020. Clinical characteristics. Most individuals with classic GBE1 adult polyglucosan body disease (GBE1-APBD) present after age 40 years with unexplained progressive neurogenic bl[...]Article
Oliveira J ; Parente Freixo J ; Santos M ; Coelho T | 17/09/2020Initial Posting: June 7, 2012; Last Update: September 17, 2020. Clinical characteristics. The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy t[...]Article
Chrestian N | 27/08/2020Initial Posting: September 28, 1998; Last Update: August 27, 2020. Clinical characteristics. Hereditary neuropathy with liability to pressure palsies (HNPP) is characterized by recurrent acute sensory and motor neuropathy in a single or mu[...]Article
Update : 2020 August. (Last Update: March 19, 2023)Article
Dermatomyositis is a rare acquired immune-mediated muscle disease characterized by muscle weakness and skin rash. It is classified as one of the idiopathic inflammatory myopathies (IIM). Although all idiopathic inflammatory myopathies share the [...]Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]Article
Prasun P | 18/06/2020Clinical characteristics. Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenita[...]Article
Mancheno N ; Braza-Boils A ; Muelas N ; Ejarque-Domenech I ; Martinez-Dolz L ; Zorio E | Spain | 06/2020Article
Zuchner S | 14/05/2020Initial Posting: February 18, 2005; Last Update: May 14, 2020. Clinical characteristics. MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal domi[...]